BetterLife Pharma (QB) Stock Price

0.00136 (0.17%)
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
BetterLife Pharma Inc (QB) BETRF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00136 0.17% 0.80936 16:00:07
Open Price Low Price High Price Close Price Prev Close
0.795124 0.781325 0.853 0.80936 0.808
Bid Price Ask Price Spread News
0.7735 0.8641 0.0906 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
39 29,655 $ 0.808434 $ 23,974 - 0.0993 - 2.21
Last Trade Time Type Quantity Stock Price Currency
15:50:58 222 $ 0.80936 USD

BetterLife Pharma (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 43.27M 53.46M 26.00M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
535.00 $ - 0.00% - -

more financials information »

BetterLife Pharma (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BETRF Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.9951.03030.78080.867445845,039-0.18564-18.66%
1 Month1.131.2190.78080.984406845,134-0.32064-28.38%
3 Months1.231.650.78081.2079,680-0.42064-34.2%
6 Months0.651.770.251.1974,9080.1593624.52%
1 Year0.12632.210.09931.1161,8510.68306540.82%
3 Years0.12632.210.09931.1161,8510.68306540.82%
5 Years0.12632.210.09931.1161,8510.68306540.82%

BetterLife Pharma (QB) Description

BetterLife Pharma Inc. ("BetterLife") is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Through its wholly owned subsidiary, Altum Pharmaceuticals Inc., BetterLife is refining and developing drug candidates from a broad set of complementary Interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus (HPV), and/or to directly inhibit tumours to treat specific types of cancer.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.